Symrise Ag

Fresenius Ag

Justus-liebig-universitaet Giessen

Justus-liebig-universität Gießen

Novigo Gmbh & Co. Kg

Peter Mayser

Gerhard Schmaus

Klaus Sommermeyer

Manuel Pesaro

Nikolas Bugdahn

Burghard Weidler

Friedrich Grimminger

Ewald Schlotzer

Werner Seeger

Jessica Grieger

Martin Thomas

The present invention primarily relates to a fatty acid ester or mixture of two or more fatty acid esters or mixture comprising one or more fatty acid esters, wherein the fatty acid ester or one, two, three or more, preferably all, of the fatty acid ester(s) is/are selected from the group consisting of 3-hydroxypropyl caprylate, glyceryl monocaprylate, 3-hydroxypropyl undecylenate and glyceryl monoundecylenate, for use in the treatment of an excess ofon the skin surface of mammals, preferably of humans. The present invention further relates to particular mixtures or products, and to the cosmetic, non-therapeutic use of fatty acid esters or of mixtures or products comprising fatty acid esters as defined herein to reduce the amount ofon the skin surface of mammals, preferably of humans.

Fatty acid esters as anti-agents

The present invention concerns an agent for prevention and treatment of pityriasis. The agent according to the present invention comprises at least one transaminase inhibitor effectively inhibiting the transamination process which is of pathogenetic relevance for the disease, prevents a recurrence of the disease and which protects the human skin flora. Upon release into the environment, no resistances are induced in other fungi.

Agent for preventing and treating pityriasis versicolor

Use of an emulsion to prepare an intravensously administered medicament

Growing community of inventors

Biebertal, Germany

Peter Mayser